| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.14B | $2.04B | $1.78B |
| YoY Revenue Growth % | +5.1% | +14.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $770.8M | $629.1M | $638.8M |
| Operating Margin % | 36.0% | 30.9% | 35.8% |
| Net Income (GAAP) | $554.4M | $375.7M | $629.3M |
| EBITDA (Normalized) | $785.5M | $702.4M | $703.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.12B | $1.01B | $1.07B |
| Capital Expenditures (CapEx) | $18.4M | $91.7M | $80.3M |
| Free Cash Flow (FCF) | $1.10B | $914.0M | $991.4M |
| FCF Margin % | 51.5% | 44.9% | 55.6% |
| Return on Invested Capital (ROIC %) | 4.3% | 3.5% | 9.3% |
| Cash & Short-Term Equivalents | $211.6M | $688.6M | — |
| Total Debt (Short + Long Term) | $4.10B | $4.26B | $2.11B |
| Total Stockholders' Equity | $10.39B | $10.65B | $4.32B |